94 results on '"Jansz P"'
Search Results
2. Six-Month Outcomes After High-Risk Coronary Artery Bypass Graft Surgery and Preoperative Intra-aortic Balloon Counterpulsation Use: An Inception Cohort Study
3. Outpatient Management of Intra-Corporeal Left Ventricular Assist Device System in Children: A Multi-Center Experience
4. (1004) - Subaortic Pannus Causing Complete Outlet Obstruction After Bioprosthetic Aortic Valve Replacement in Left Ventricular Assist Device Patient
5. (230) - Never Too Old to Join the Pool - Heart Transplantation From Older Donation After Circulatory Death Donors in Australia
6. (233) - Donation After Circulatory Death Heart Transplantation - Withdrawal Practices and Location Matter!
7. (207) - Satisfactory Short and Long-Term Outcomes from Careful Selection of Older Donors for Lung Transplantation: An Australian Single-Centre Experience
8. (96) - Initial Single Centre Experience with The XVIVO Hypothermic Perfusion System: Outcomes from the First 32 Cases
9. (45) - Utilizing All the Tools in the ‘Box’ for Heart Transplantation
10. Combining Cariporide with Glyceryl Trinitrate Optimizes Cardiac Preservation During Porcine Heart Transplantation
11. (398) Favorable Impact of Hypothermic Machine Perfusion (HMP) on Early Renal Outcomes in Patients Undergoing Heart Transplantation Using Prolonged (6-8 Hour) Donor Hearts
12. (382) Pre-Clinical Development & Testing of the CorWave Membrane LVAD
13. (381) Left Ventricular Contractile Reserve is Associated with Optimal Exercise Hemodynamics in Cf-lvad Patients: A Pressure-Volume Loop Analysis
14. (1059) Peri-Operative Transfusion Requirements and ICU Length of Stay after Heart Transplantation for Patients with LVADs Anticoagulated with Apixaban - Initial Experience
15. (773) Rethinking Early Clinical Trials: Design of the CorWave LVAD Feasibility Trial
16. (122) Influence of Hypothermic Machine Perfusion (HMP) on Donor Heart Function Following an Ischemic Time of 6-8 Hours
17. (117) Initial Australian Experience with the Xvivo Non-Ischaemic Hypothermic Perfusion Device for Heart Preservation
18. (111) Pushing The Boundaries of Donation After Circulatory Death Heart Transplantation - The Australian Experience
19. Baseline Ventricular Assist Device (VAD) Flow as a Potential Marker of Increased Morbidity and Mortality Risk During Blood Stream Infection (BSIs) in Patients with Fixed Pump Speed
20. Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients
21. Comparing Velocity and Mean Arterial Pressure to Assess Pulsatility in Patients with Continuous Flow Left Ventricular Assist Devices
22. Marginal Cardiac Donors and Transplant Outcomes: An 11-Year Experience
23. Comparison of Outcomes Following Physician Directed Bolus vs. Strict Infusion Protocol of Tissue Plasminogen Activator for Thrombolytic Treatment of Pump Thrombosis
24. Exploring the Benefit of Thoracotomy LVAD Implant on Subsequent Sternal Entry for Heart Transplantation
25. Heart Transplantation from Donation After Circulatory Death Donors: An Update on the Australian Experience
26. Development of a Donor-Recipient Matching Algorithm for Lung Transplantation in Australia
27. Extracorporeal Membrane Oxygenation for Primary Graft Failure Following Heart Transplantation
28. Comparing HVAD Inflow Cannula Angle between Median Sternotomy and Thoracotomy
29. Anatomical Human Fitting of the Bivacor Total Artificial Heart
30. Bloody Transplants! Impact of Prior Sternotomy on Transfusion Rate in Heart Transplantation
31. Impact of COVID-19 on Lung Transplantation in Australia
32. Hypertension, Arterial Compliance and LVAD Pump Function
33. First in Man Anatomical Fitting Study of the BiVACOR Total Artificial Heart
34. Outcomes of Patients with Chronic Thromboembolic Pulmonary Hypertension Risk Stratified by a Dedicated Heart Team to Receive Pulmonary Endarectomy or Balloon Pulmonary Angiogiplasty
35. Vasopressor Requirement in Patients Undergoing Ventricular Assist Device Explant and Heart Transplant
36. Echocardiographic Outcomes Following Left Ventricular Assist Device or Mitral Valve Repair in Severe Left Ventricular Dilatation with Mitral Regurgitation
37. Pump Thrombosis, Scratching the Surface
38. Lavare Cycle Does Not Induce Pulsatility in CF-LVAD Patients
39. Inspiratory Breath-Hold - A Simple Clinical Intervention to Assess Risk Threshold for Suction Events in Stable LVAD Outpatients
40. Acoustic Characterisation of the HeartWare Left Ventricular Assist Device
41. Unexpected Contribution of Pulsatility to Pump Thrombosis
42. A Study of Infected Drivelines from Ventricular Assist Device Patients: The Presence of Microbial Biofilms and Micro-Gaps in the Driveline Tunnel
43. (685) - Predictive Value of I-CARS for LV Recovery in an Unselected cf-LVAD Cohort
44. (352) - Evidence for Subclinical, Progressive Outflow Graft Stenosis in Patients With Heartware HVAD
45. (341) - Continuous-flow LVAD Therapy: A ‘Forme-fruste’ of Diastolic Heart Failure
46. (305) - Reversibility of Fried’s Physical Frailty Domains Post- Ventricular-Assist Device Implantation Among Patients with Advanced Heart Failure
47. (100) - Frailty Predicts Mortality After Heart Transplantation
48. (9) - Donation After Circulatory Death (DCD) Heart Transplantation in Australia: An Update of Current Practises and Outcomes
49. (1310) - Cerebrovascular Events in Patients with Continuous Flow Left Ventricular Assist Devices
50. (1081) - Beat-to-Beat Detection of Aortic Valve Opening in Continuous Flow LVAD Patients with Irregular Cardiac Rhythm and with Hemodynamic Maneuvers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.